The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Applications of nanoparticles in ophthalmology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
The role of cerium redox state in the SOD mimetic activity of nanoceria
Heckert, E. G., Karakoti, A. S., Seal, S., & Self, W. T. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.03.014 · Cited by 1,014
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
The present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
Chen, J., Patil, S., Seal, S., & McGinnis, J. F. (2006) · Nature Nanotechnology · doi:10.1038/nnano.2006.91 · Cited by 880
Vacancy Engineered Ceria Nanostructures for Protection from Radiation-Induced Cellular Damage
Tarnuzzer, R. W., Colon, J., Patil, S., & Seal, S. (2005) · Nano Letters · doi:10.1021/nl052024f · Cited by 816
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
Hélène, C., & Toulmé, J.-J. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90031-v · Cited by 768
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons
Das, M., Patil, S., Bhargava, N., Kang, J.-F., Riedel, L. M., Seal, S., & Hickman, J. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.036 · Cited by 760
Nanoparticles: pharmacological and toxicological significance
Medina, C., Santos‐Martinez, M. J., Radomski, A., Corrigan, O. I., & Radomski, M. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707130 · Cited by 738
Characterization of oligonucleotide transport into living cells.
Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., & Neckers, L. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3474 · Cited by 734
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J.-J., Sumaroka, A., Windsor, E. A. M., Wilson, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807027105 · Cited by 673
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Nanotechnology for the biologist
McNeil, S. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205074 · Cited by 613
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Antiangiogenic properties of silver nanoparticles
Gurunathan, S., Lee, K.-J., Kalishwaralal, K., Sheikpranbabu, S., Vaidyanathan, R., & Eom, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.008 · Cited by 562
MOTWANI, S., CHOPRA, S., TALEGAONKAR, S., KOHLI, K., AHMAD, F., & KHAR, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.09.009 · Cited by 557
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Ultrasound mediated delivery of drugs and genes to solid tumors
Frenkel, V. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.007 · Cited by 474
Development of in vitro systems for nanotoxicology: methodological considerations
Stone, V., Johnston, H., & Schins, R. P. F. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903120975 · Cited by 427
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
Progress and prospects: naked DNA gene transfer and therapy
Herweijer, H., & Wolff, J. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301983 · Cited by 407
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Self-citationRNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Ocular absorption following topical delivery
Järvinen, K., Järvinen, T., & Urtti, A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00010-5 · Cited by 358
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
The potential of chitosan in ocular drug delivery
Alonso, M. J., & Sánchez, A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022476 · Cited by 352
Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen
Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350
Grimm, D., & Kay, M. (2003) · Current Gene Therapy · doi:10.2174/1566523034578285 · Cited by 350
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Ocular Preparations: The Formulation Approach
Pal Kaur, I., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
de la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1077 · Cited by 287
de Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Self-citationTransscleral drug delivery for posterior segment disease
Geroski, D. H., & Edelhauser, H. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00193-4 · Cited by 282
Aptamers—basic research, drug development, and clinical applications
Proske, D., Blank, M., Buhmann, R., & Resch, A. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0193-5 · Cited by 281
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Diebold, Y., Jarrín, M., Sáez, V., Carvalho, E. L. S., Orea, M., Calonge, M., Seijo, B., & Alonso, M. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.028 · Cited by 273
Self-citationNanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen, K. M., Kananen, K., Auriola, S. O. K., Kontturi, K., & Urtti, A. O. (1997) · PubMed · Cited by 266
Single-Walled and Multi-Walled Carbon Nanotubes Promote Allergic Immune Responses in Mice
Nygaard, U. C., Hansen, J. S., Samuelsen, M., Alberg, T., Marioara, C. D., & Løvik, M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp057 · Cited by 263
Gold nanoparticles enable selective light-induced contents release from liposomes
Paasonen, L., Laaksonen, T., Johans, C., Yliperttula, M., Kontturi, K., & Urtti, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.009 · Cited by 252
Nanoparticulates as Drug Carriers
Torchilin, V. P. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/p432 · Cited by 248
De Campos, A. M., Sánchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00178-7 · Cited by 234
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties
Merodio, M., Arnedo, A., Renedo, M. J., & Irache, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00169-x · Cited by 233
Kim, J. H., Kim, J. H., Kim, K.-W., Kim, M. H., & Yu, Y. S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/50/505101 · Cited by 226
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000038 · Cited by 208
Szebeni, J., Alving, C. R., Rosivall, L., Bünger, R., Baranyi, L., Bedöcs, P., Tóth, M., & Barenholz, Y. (2007) · Journal of Liposome Research · doi:10.1080/08982100701375118 · Cited by 199
Nanocapsules: A new type of lysosomotropic carrier
Couvreur, P., Tulkenst, P., Roland, M., Trouet, A., & Speiser, P. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80717-5 · Cited by 197
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189
Ocular Drug Delivery: Pharmacokinetic Considerations
Schoenwald, R. D. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018040-00001 · Cited by 183
Nanoparticles for gene delivery to retinal pigment epithelial cells.
Bejjani, R. A., BenEzra, D., Cohen, H., Rieger, J., Andrieu‐Soler, C., Jeanny, J., Gollomb, G., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 176
Losa, C., Marchal-Heussler, L., Orallo, F., Jato, J. L. V., & Alonso, M. J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018977130559 · Cited by 163
Smaller is not always better: nanotechnology yields nanotoxicology
Kipen, H. M., & Laskin, D. L. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00277.2005 · Cited by 161
Johnson, L. N., Cashman, S. M., & Kumar-Singh, R. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300324 · Cited by 161
Qaddoumi, M. G., Gukasyan, H. J., Davda, J. P., Labhasetwar, V. D., Kim, K. J., & Lee, V. H. L. (2003) · PubMed · Cited by 157
Hsiue, G., Hsu, S., Yang, C.-C., Lee, S., & Yang, I.-K. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00127-2 · Cited by 155
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
Fattal, E., & Bochot, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.020 · Cited by 152
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149
Wadhwa, S., Paliwal, R., Paliwal, S. R., & Vyas, S. P. (2009) · Journal of drug targeting · doi:10.3109/10611860903450023 · Cited by 149
Permeability and Diffusion in Vitreous Humor: Implications for Drug Delivery
Xu, J., Heys, J. J., Barocas, V. H., & Randolph, T. W. (2000) · Pharmaceutical Research · doi:10.1023/a:1007517912927 · Cited by 147
Controlled Delivery of Peptides and Proteins
Değim, İ. T., & Çelebi, N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313795 · Cited by 147
Early adverse events, HPA activity and rostral anterior cingulate volume in MDD
Treadway, M. T., Grant, M. M., Ding, Z., Hollon, S. D., Gore, J. C., & Shelton, R. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004887 · Cited by 142
Adeno-associated virus expression systems for gene transfer
Rabinowitz, J. E., & Samulski, J. R. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80031-1 · Cited by 142
Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration
Vega, E., Egea, M. A., Valls, O., Espina, M., & García, M. L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20685 · Cited by 137
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene.
Mo, Y., Barnett, M. E., Takemoto, D. J., Davidson, H. J., & Kompella, U. B. (2007) · PubMed Central · Cited by 133
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Fattal, E., & Bochot, A. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.011 · Cited by 124
Adeno-associated virus-mediated gene delivery
Snyder, R. O. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3<166::aid-jgm34>3.0.co;2-z · Cited by 118
Nanoceria have no genotoxic effect on human lens epithelial cells
Pierscionek, B. K., Li, Y., Yasseen, A. A., Colhoun, L. M., Schachar, R. A., & Chen, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/21/3/035102 · Cited by 118
Campochiaro, P. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302653 · Cited by 116
Ocular Drug Delivery: Nanomedicine Applications
Vandervoort, J., & Ludwig, A. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.11 · Cited by 114
Immune response following intraocular delivery of recombinant viral vectors
Bennett, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302030 · Cited by 111
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
Calvo, P., Sánchez, A., Martínez, J., López, M. I., Calonge, M., Jimeno, J. C. P., & Alonso, M. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016015803611 · Cited by 108
Self-citationChitosan nanoparticles for drug delivery to the eye
Paolicelli, P., de la Fuente, M., Sánchez, A., Seijo, B., & Alonso, M. J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902762818 · Cited by 108
Studies on the transport pathway of PBCA nanoparticles in ocular tissues
Zimmer, A., Kreuter, J., & Robinson, J. R. (1991) · Journal of Microencapsulation · doi:10.3109/02652049109021873 · Cited by 102
Losa, C., Calvo, P., Castro, E., Vila-Jato, J. L., & Alonso, M. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03534.x · Cited by 102
del Pozo‐Rodríguez, A., Delgado, D., Solinís, M. Á., Rodríguez‐Gascón, A., & Pedraz, J. L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.023 · Cited by 100
Yenice, İ., Mocan, M. C., Palaska, E., Bochot, A., Bilensoy, E., Vural, İ., Irkec, M. T., & Hıncal, A. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.002 · Cited by 99
Park, K., Chen, Y., Hu, Y., Mayo, A. S., Kompella, U. B., Longeras, R., & Ma, J. (2009) · Diabetes · doi:10.2337/db08-1327 · Cited by 97
Studies on the Mechanism of Nitro Reduction by Rat Liver
Kato, R., Oshima, T., & Takanaka, A. (1969) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14691-9 · Cited by 97
Ultrapure chitosan oligomers as carriers for corneal gene transfer
Klausner, E. A., Zhang, Z., Chapman, R. L., Multack, R. F., & Volin, M. V. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.031 · Cited by 95
Non-viral ocular gene therapy: Potential ocular therapeutic avenues
Bloquel, C., Bourges, J., Touchard, E., Berdugo, M., BenEzra, D., & Béhar‐Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.023 · Cited by 93
Titanium Dioxide Nanoparticles Aggravate Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice
Yanagisawa, R., Takano, H., Inoue, K., Koike, E., Kamachi, T., Sadakane, K., & Ichinose, T. (2009) · Experimental Biology and Medicine · doi:10.3181/0810-rm-304 · Cited by 88
Sakai, T., Kohno, H., Ishihara, T., Higaki, M., Saitô, S., Matsushima, M., Mizushima, Y., & Kitahara, K. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.09.003 · Cited by 84
Ocular drug delivery of progesterone using nanoparticles
Li, V. H. K., Wood, R. W., Kreuter, J., Harmia, T., & Robinson, J. R. (1986) · Journal of Microencapsulation · doi:10.3109/02652048609031575 · Cited by 83
Baeyens, V., & Gurny, R. (1997) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(97)00021-6 · Cited by 82
Kachi, S., Oshima, Y., Esumi, N., Kachi, M., Rogers, B. S., Zack, D. J., & Campochiaro, P. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302475 · Cited by 80
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2009) · Current Eye Research · doi:10.1080/02713680903017500 · Cited by 80
Toxicity of nanomaterials to the eye
Prow, T. W. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.65 · Cited by 77
Formulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expression
Kiang, T., Bright, C., Cheung, C., Stayton, P. S., Hoffman, A. S., & Leong, K. W. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562042368112 · Cited by 76
Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina
Ding, X., Quiambao, A. B., Fitzgerald, J. B., Cooper, M. J., Conley, S. M., & Naash, M. I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007410 · Cited by 75
Nanoparticulates as Drug Carriers
(2007) · Nano Today · doi:10.1016/s1748-0132(07)70060-9 · Cited by 75
Recent developments in ocular gene therapy
Borrás, T. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00030-7 · Cited by 74
Development of New Drugs in Angiogenesis
Ziche, M., Donnini, S., & Morbidelli, L. (2004) · Current Drug Targets · doi:10.2174/1389450043345371 · Cited by 70
Nanoparticle-Cell Interactions: Drug Delivery Implications
Harush-Frenkel, O., Altschuler, Y., & Benita, S. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i6.10 · Cited by 62
Controlled Gene Gun Delivery and Expression of DNA Within the Cornea
Tanelian, D. L., Barry, M. A., Johnston, S. A., Le, T. T., & Smith, G. M. (1997) · BioTechniques · doi:10.2144/97233st06 · Cited by 59
Ocular Tolerance to a Topical Formulation of Hyaluronic Acid and Chitosan-Based Nanoparticles
Contreras‐Ruiz, L., de la Fuente, M., García‐Vázquez, C., Sáez, V., Seijo, B., Alonso, M. J., Calonge, M., & Diebold, Y. (2010) · Cornea · doi:10.1097/ico.0b013e3181bd9eee · Cited by 58
Self-citationSingle walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure
Panessa‐Warren, B. J., Maye, M. M., Warren, J. B., & Crosson, K. M. (2009) · Environmental Pollution · doi:10.1016/j.envpol.2008.12.028 · Cited by 54
Size Effects of Polystyrene Nanoparticles on Atopic Dermatitis-like Skin Lesions in NC/NGA Mice
Yanagisawa, R., Takano, H., Inoue, K. ‐., Koike, E., Sadakane, K., & Ichinose, T. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300112 · Cited by 44
Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye
Hayashi, A., Naseri, A., Pennesi, M. E., & de Juan, E. (2009) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-009-0655-x · Cited by 43
Assessing immunotoxicity: guidelines
Putman, E., van der Laan, J. W., & Loveren, H. V. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00181.x · Cited by 42
VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand, N., Valamanesh, F., Savoldelli, M., Mascarelli, F., BenEzra, D., Courtois, Y., & Béhar‐Cohen, F. (2005) · PubMed · Cited by 41
Toyama, T., Matsuda, H., Ishida, I., Tani, M., Kitaba, S., Sano, S., & Katayama, I. (2008) · Contact Dermatitis · doi:10.1111/j.1600-0536.2008.01340.x · Cited by 40
Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors
Ralph, G. S., Binley, K., Wong, L., Azzouz, M., & Mazarakis, N. D. (2005) · Clinical Science · doi:10.1042/cs20050158 · Cited by 36
pH-Dependent Disruption of Erythrocyte Membrane by Amphiphilic Poly(amino acid) Nanoparticles
Akagi, T., Kim, H., & Akashi, M. (2010) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856209x418519 · Cited by 36
Visualizing Vitreous Using Quantum Dots as Imaging Agents
Yamamoto, S., Manabe, N., Fujioka, K., Hoshino, A., & Yamamoto, K. (2007) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2007.891883 · Cited by 29
Snodin, D. J. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.08.007 · Cited by 27
Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat
Juberías, J. R., Calonge, M., Gómez, S., et al. (1998) · Current Eye Research · doi:10.1076/ceyr.17.1.39.5251 · Cited by 26
Self-citationRoy, K., Stein, L. F., & Kaushal, S. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.041 · Cited by 23
Gene therapy for retinal and choroidal diseases
Campochiaro, P. A. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.5.537 · Cited by 23
Cited by
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Sosnik, A., das Neves, J., & Sarmento, B. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.07.010 · Cited by 487
Bachu, R., Chowdhury, P., Al-Saedi, Z., Karla, P., & Boddu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 421
Advances and limitations of drug delivery systems formulated as eye drops
Jumelle, C., Gholizadeh, S., Annabi, N., & Dana, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.057 · Cited by 408
Metadata
- Authors
- Diebold, Y., & Calonge, M.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 29
- Issue
- 6
- Pages
- 596-609
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W1990842129
- Cited by
- 392
- References
- 126
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.